INTRODUCTION
Researchers have put forward the hypothesis that asthma and chronic obstructive pulmonary disease (COPD) should be considered different manifestations of similar and related conditions [1] . According to this theory, asthma and COPD share risk factors, both environmental and genetic, and depending on a patient's particular circumstances, that patient is more inclined to develop one or the other [2] . Although proof of this theory is difficult to conclusively demonstrate, it is now clear that childhood asthma is one of the first manifestations of a longitudinal lung function trajectory likely to result in eventual COPD.
Childhood asthma is associated with reductions in pulmonary function, frequently measured in forced expiratory volume in 1 s (FEV 1 ), or the ratio of FEV 1 to forced vital capacity (FVC), whereas COPD is defined by an FEV 1 /FVC ratio less than 0.70. Thus, while the evidence reviewed below makes it clear that childhood asthma accompanies a lung function deficit which is likely to persist throughout adulthood, and that can in turn result in early or more severe COPD, it is still unclear whether asthma causes lower lung function, is a symptom of it or just merely co-occurs.
Furthermore, there is a growing appreciation that asthma and COPD are not always separate conditions. In the Asthma-COPD Overlap Syndrome (ACOS), asthma and COPD co-occur in the same patient. It is a condition characterized by a significant fixed airway obstruction and also a significant component of reversible airway obstruction, wherein the diagnosis of ACOS is made on a sliding scale of symptoms characteristic of asthma, COPD or both [3 & ]. People with asthma that persists through adulthood, together with reduced lung function, are at risk of developing ACOS and not just COPD [4] . Recent work has shown that ACOS is generally more of a burden on the healthcare system [5] , and confers almost double the risk of respiratory hospitalization than those with just COPD [6] .
CHILDHOOD COHORTS
There have been many longitudinal studies of lung function, including many population studies, which have shown a relationship between childhood asthma and low lung function -either reduced FEV 1 , increased decline in FEV 1 or premature onset of decline of FEV 1 -and this low lung function predisposes to eventual COPD. However, most studies of children with asthma are short enough that participants do not develop clinical COPD. Similarly, there have been studies of older populations where COPD is evident, and these studies have identified an association between current and remembered childhood asthma with the prevalence and onset of adult COPD. There have been few studies that have followed individuals long enough to observe childhood asthma and adult COPD in the same patients, although there are two population cohorts with 50 or more years between enrollment and latest recontact -and it seems likely that these studies will continue with even longer follow-up. By looking at the combination of population studies of pulmonary function, which span from prenatal times and infancy to at least the mid-60s (Fig. 1) , it is clear that childhood asthma is associated with impaired lung function which is a defining feature of adult COPD.
The Copenhagen Prospective Studies on Asthma in Childhood (COPSAC) cohort is one of several studies to identify children at risk for asthma prenatally. COPSAC prospectively enrolled 411 at-risk children during 1998-2001 [7] , and followed them for at least 7 years. By age 7, 14% had asthma, and this was associated with a lung function deficit present as infants and persisting to age 7, as well as increased bronchial responsiveness [8] . Lung function deficits were also shown to increase from infancy through age 7. This study [9] also showed a remarkable association between childhood asthma, persistent childhood wheeze and neonatal bronchial infection.
Similarly, the Manchester Asthma and Allergy Study (Manchester) identified prenatal children and followed them to age 11, encompassing up to 1184 individuals with at least 829 completing spirometry at any time point. This study [10] showed that a
KEY POINTS
There are dozens of studies showing an association between childhood asthma and reduced lung function.
Reduced lung function tends to persist; baseline lung function is a strong predictor of later lung function.
Several studies have shown that asthma is a risk factor for COPD or undiagnosed chronic airway obstruction. persistent low lung function trajectory starting at age 3 was associated with subsequent persistence of wheezing, a precursor of asthma.
Another study of prenatal asthmatic patients, the Environment and Childhood Asthma study [11] , took place in Oslo, measuring lung function at birth in 329 individuals, and again at 10 and 16 years. The Oslo study [11] determined that children with worse asthma or asthma with comorbidities (atopic dermatitis and allergic rhinitis) had impaired lung function compared with those only with asthma or those with asthma in remission, as well as to healthy controls.
In Sweden, the BAMSE cohort study [12] was designed to investigate lung function and lung function growth in relation to asthma phenotypes and symptoms. BAMSE enrolled children before birth and followed them to at least age 16, finding that asthma onset before age 4 was associated with impaired spirometric flow at age 8, regardless of intervening symptom activity, with more than 2700 children providing measurements [12] .
The Tucson Children's Respiratory Study (Tucson CRS) extended the result that infant lung function tests strongly predict adult lung function. Tucson CRS was a population cohort with 123 infants with spirometry measurements up through age 23 [13] . In a further follow-up, 599 individuals showed a stable, low lung function trajectory from age 11 to 32, with spirometry taken every 4-6 years [14 && ]. These studies demonstrate that when low lung function accompanies childhood asthma, that low lung function tends to persist into adulthood.
A long-term population cohort in Dunedin, New Zealand, brought these results further, showing that 40% of persistent childhood asthmatic patients have chronic airway obstruction [15 && ]. This cohort was followed from birth to age 38, comprising 1037 total individuals. They observed that FEV 1 was lower in early childhood for those children who went on to develop childhood asthma [15 && ]. In addition, they identified lung function groups from ages 9 to 23, where reduced lung function groups were associated with persistent wheeze [16] .
In a focused recruitment of young children with diagnosed, persistent, mild-to-moderate asthma, the Childhood Asthma Management Program (CAMP) has now followed up to 1041 asthmatic patients from ages 5-12 years to 23-30 years [17, 18] . CAMP is another study [19] that was able to associate reduced lung function with asthma. However, with at least annual spirometry, the CAMP study was also able to identify different trajectories that lead to adult chronic airway obstruction. It was observed that CAMP individuals could be categorized as having reduced lung function, if they were below expected FEV 1 for a person of the same age, sex, height and race, or early decline of lung function, if they tracked along normal levels of FEV 1 for a time, but then began to decline earlier than expected [20 & ]. Previous work had identified a plateau period of FEV 1 , where FEV 1 level was neither increasing with growth nor decreasing with aging, from the ages of 15 in girls or 20 in boys to age 25 [21] . By age 30, 11% of the CAMP individuals qualified for COPD by spirometric criteria, and these were a mix of those individuals displaying the reduced FEV 1 pattern and the early decline FEV 1 pattern [20 & ]. Other studies associated childhood wheeze with lung function deficits [22] . One such study was the Melbourne Atopy Cohort Study (MACS), which recruited 620 children from a birth cohort with allergy or atopy, and stratified individuals by type of wheeze and allergic disease. MACS was able to show that early-onset, intermediate-onset and lateonset wheezers were associated with lower lung function growth over the 6-year period from ages 12 to 18 [23] .
A group of 119 asthmatic patients was followed from the age of 9 to 27 in Groningen, The Netherlands, showing that bronchial hyperresponsiveness and a low level of lung function in childhood are independent risk factors for a low level of FEV 1 in early adulthood [24] .
A group of 346 asthmatic patients called the Melbourne Asthma Cohort (MAC) was recruited from a 1957 birth cohort [25] at the age of 7 and followed for 50 years. The MAC cohort was able to identify children with asthma and follow them long enough to observe an increased risk of COPD at age 57, finding that baseline asthma conferred an adjusted 32-fold odds of developing COPD [26] . Interestingly, they saw no differences in rate of decline of FEV 1 for normal controls, persistent asthmatic patients, asthma in remission and COPD.
Another cohort was followed for 50 years in Aberdeen: the WHEASE (What Happens Eventually to Asthmatic children: Sociologically and Epidemiologically) cohort of children was recruited in 1964. WHEASE included 330 individuals, from age 10 to 15 followed to 61. WHEASE found that childhood wheeze and childhood asthma are associated with eventual COPD [27 && ]. They also found that adult onset wheezing was also associated with COPD.
ADULT COHORTS
Other longitudinal studies of adults did not directly observe childhood asthma, but frequently did directly observe adult COPD. These studies assessed the association between childhood asthma and adult COPD by using questionnaires regarding the participants' background and a memory of diagnosis of asthma or episodes of wheeze.
A general population cohort recruited in Copenhagen followed 780 individuals from ages 7 to 37 for 20 years, and examined airway hyperresponsiveness, a cardinal feature of asthma. They found that airway hyperresponsiveness was associated with reduced lung function growth, noting a decrease in maximal attained lung function for airway hyperresponsiveness, independently of asthma and smoking [28] .
Other studies were designed to investigate the effects of smoking on lung function. The Coronary Artery Risk Development in Young Adults Study enrolled 3950 adult individuals up to the age of 40, and followed them for a 10-year period. Although focused on smoking, asthma was found to contribute to faster decline in FEV 1 over the periods of observation compared with nonasthmatic patients [29] . Further follow-up for an additional 10 years showed that baseline lung function (FEV 1 /FVC) is predictive of later lung function [30] .
The European Community Respiratory Health Survey I and II (ECRHS) identified several risk factors for reduced adult lung function, including asthma, parental asthma and early life respiratory infections [31] . ECRHS enrolled 7738 adults from ages 20 to 45, assessing spirometry and again 9 years later. In addition to reduced lung function, ECRHS also showed that early life risk factors were associated with greater decline in FEV 1 across the 9-year period. ECRHS also observed onset of adult COPD, and found COPD was 10 times more likely in individuals with childhood asthma than in those without -a potential impact as large as that of heavy smoking.
Other studies were combined to investigate the onset of COPD in relation to maximally obtained adult FEV 1 levels. In an examination of 2864 individuals aged 35-40 and followed for an average of 22 years in the Framingham Offspring Cohort and Copenhagen City Heart Study, both lung function peak level and lung function rate of decline were important to the eventual development of COPD [32 && ]. The study determined that roughly half of individuals with chronic airflow obstruction had rapid decline of FEV 1 , whereas the others had reached lower maximum values of FEV 1 in early adulthood.
The Tucson Epidemiological Study of Airway Obstructive Disease (TEASOD) has contributed a number of important results related to asthma and lung function, following 2000-3000 adult individuals for over 20 years. When considering 3099 individuals enrolled as adults (mean age 45) and followed for 20 years with spirometry and surveys every 1-2 years, TEASOD researchers found that current asthma was associated with COPD at a 12-times hazard ratio, finding no risk for childhood and/or previous asthma [33] . In subsequent examinations, TEASOD researchers found that those with asthma onset prior to age 25 were more likely to have persistent airflow limitation than those who developed asthma after age 25, and that this airflow obstruction was largely established by age 25 [34] . Most recently, by following 2121 adult participants enrolled in the 70s until 2015, TEASOD researchers found that baseline FEV 1 predicted mortality, as did asthma, but asthma was not a risk factor for all-cause mortality after adjustment for baseline FEV 1 [35 & ].
CROSS-SECTIONAL STUDIES
These longitudinal cohort studies are the ideal method for investigating the relationship between childhood outcomes and adult outcomes -when the individuals can be followed from childhood through adulthood. However, the expense and effort required to closely follow a large cohort for a long period of time make such studies rare. This problem is particularly salient in pulmonary investigations where individuals must undergo spirometric assessment at regular intervals, the more the better, and these measurements often have significant variability. Nevertheless, we still obtain useful insights from cross-sectional studies and much shorter studies, where adult COPD can be readily assessed and childhood risk factors can be investigated through questionnaires.
These include the Hiroshima COPD Cohort Study, which enrolled 9896 participants prospectively across Japan, ages 35-60, and found that remitted childhood asthma associated with significantly lower FEV 1 [36 && ]. The Wellington Respiratory Survey [37] surveyed 749 people ages 25-75 for risk of COPD, and found that a previous diagnosis of asthma in childhood was equivalent to aging 22 years or to 62 pack-years of smoking toward the risk of COPD [38] . A prospective, multisite Canadian Cohort of Obstructive Lung Disease (Can-COLD) enrolled 4893 adults aged 40 years and older, identifying independent predictors of COPD: older age, self-reported asthma and lower education [39 & ]. The Busselton Study [40] found that lung function deficits early in life, associated with asthma and smoking, lead to later COPD. In a series of follow-ups of 9317 adults, Busselton showed increased decline in FEV 1 for asthma individuals. An investigation into 306 adults with confirmed asthma found that smoking, longer asthma duration, absence of inhaled corticosteroid therapy and neutrophils in induced sputum were all risk factors for persistent airflow obstruction [41] .
CONCLUSION
There is a wealth of evidence from dozens of trials showing that asthma is associated with reduced lung function. This is also the conclusion of several other reviews of asthma and lung function [42] [43] [44] . However, this leaves two important points.
First, asthma is not usually shown to be associated with clinically diagnosed COPD; and thus, we may ask if lower lung function is sufficient to establish a link between asthma and COPD. Some studies have shown that airway obstruction goes largely undiagnosed in young adults [30] . An examination of largely normal individuals in NHANES (National Health and Nutritional Examination Surveys) III and NHANES 2007-2012 showed that individuals with undiagnosed pulmonary obstruction had increased risk of mortality relative to controls [45] , although they were generally healthier than those diagnosed with lung disease. This argues that even latent airway obstruction is a condition with serious health risks [46] . However, there are now some studies that do have the followup to observe both childhood asthma and adult COPD (Aberdeen, Melbourne), over their 50-year observation periods.
And second, there is a tradeoff between much longer follow-up and the difficulty and expense in providing detailed and frequent assessments of spirometry and morbidities, and the risk of greater losses to study drop out. In shorter studies, much more detailed observations have been conducted; for example the CAMP study provided at least annual spirometry through 16-18 years of observation. With frequent observation through the ages of 18-25, CAMP was able to identify early decline of lung function, as distinct from other forms of respiratory insufficiency commonly shown to lead to COPD: reduced maximal lung function and rapid lung function decline. Although additional observation through these ages is needed in replication trials, this is a result that complements the others here: not only does poor lung function from early childhood pose a risk to adult lung function, but so does normal growth through childhood that then declines earlier than expected.
A number of excellent longitudinal and crosssectional studies together draw a picture of asthma as an important risk factor and precursor to lower lung function and chronic airway obstruction. With continued investigation, this picture will resolve with increasing detail and clarity. Children with asthma, especially those with more severe disease, should undergo spirometry at least annually to assess the risk of future, early-onset chronic obstruction. Assessments of environmental or therapeutic interventions should be conducted to determine if they can ameliorate poor lung function development, from neonatal interventions through adolescence. Finally, it will be important to develop new treatments and management strategies that prevent or slow lung function deterioration, and that may possibly help adolescents achieve higher maximal lung function levels in early adulthood.
